日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Non-invasive tests to guide hepatocellular carcinoma surveillance

用于指导肝细胞癌监测的非侵入性检测

Embacher, Jan; Remih, Katharina; Schneider, Carolin Victoria; Jachs, Mathias; Balcar, Lorenz; Thöne, Paul; Sebesta, Christian; Dominik, Nina; Kramer, Georg; Hofer, Benedikt Silvester; Hartl, Lukas; Simbrunner, Benedikt; Scheiner, Bernhard; Pinter, Matthias; Trauner, Michael; Reiberger, Thomas; Strnad, Pavel; Semmler, Georg; Mandorfer, Mattias

Reproducible safety and efficacy of durvalumab with or without tremelimumab for hepatocellular carcinoma in clinical practice: Results of the DT-real study

度伐利尤单抗联合或不联合曲美利尤单抗治疗肝细胞癌在临床实践中具有可重复的安全性和有效性:DT-real 研究结果

Celsa, Ciro; Pressiani, Tiziana; Nishida, Naoshi; Chamseddine, Shadi Mohamad; Arvind, Ashwini; Li, Michael; Fortuny, Marta; Khaled, Najib Ben; Iavarone, Massimo; Toyoda, Hidenori; Rapposelli, Ilario Giovanni; Casadei-Gardini, Andrea; Vivaldi, Caterina; Ulahannan, Susanna; Andanamala, Haripriya; Scheiner, Bernhard; Pinter, Matthias; Orlandi, Elena; Fulgenzi, Claudia A M; Manfredi, Giulia F; Lombardi, Pasquale; D'Alessio, Antonio; Stefanini, Bernardo; Villani, Rosanna; Ponziani, Francesca Romana; Stella, Leonardo; Carminati, Ornella; Ricci, Angela Dalia; Gonzalez, Melina; Sparacino, Alba; Di Maria, Gabriele; Vaccaro, Marco; Cabibbo, Giuseppe; Cammà, Calogero; Reig, Maria; Kelley, Robin K; Singal, Amit G; Kaseb, Ahmed O; Kudo, Masatoshi; Rimassa, Lorenza; Pinato, David James

The Alpha-1 Pi*MZ Genotype Is an Independent Risk Factor for Hepatocellular Carcinoma Development in Patients With ACLD

α-1 Pi*MZ 基因型是 ACLD 患者发生肝细胞癌的独立危险因素。

Balcar, Lorenz; Semmler, Georg; Scheiner, Bernhard; Paternostro, Rafael; Simbrunner, Benedikt; Haunold, Tina Jasmin; Jachs, Mathias; Hartl, Lukas; Hofer, Benedikt Silvester; Dominik, Nina; Schwarz, Michael; Kramer, Georg; Sebesta, Christian; Thöne, Paul; Pinter, Matthias; Trauner, Michael; Reiberger, Thomas; Stättermayer, Albert Friedrich; Mandorfer, Mattias

Biomarkers of Extracellular Matrix Remodelling Are Linked to Severity and Outcome of Advanced Chronic Liver Disease

细胞外基质重塑的生物标志物与晚期慢性肝病的严重程度和预后相关

Simbrunner, Benedikt; Villesen, Ida Falk; Semmler, Georg; Balcar, Lorenz; Kramer, Georg; Almeida Calvão, Joana; Hofer, Benedikt Silvester; Jachs, Mathias; Hartl, Lukas; Maurer, Jurij; Scheiner, Bernhard; Zinober, Kerstin; Marculescu, Rodrig; Trauner, Michael; Karsdal, Morten; Reiberger, Thomas; Mandorfer, Mattias; Leeming, Diana Julie

Radiomics-Based Assessment of Portal Hypertension Severity and Risk Stratification of Cirrhotic Patients Using Routine CT Scans

基于放射组学的常规CT扫描评估门静脉高压严重程度及肝硬化患者风险分层

Sin, Celine; Watzenboeck, Martin Luther; Iofinova, Eugenia; Balcar, Lorenz; Semmler, Georg; Scheiner, Bernhard; Lampichler, Katharina; Mandorfer, Mattias; Moga, Lucile; Rautou, Pierre-Emmanuel; Ronot, Maxime; Menche, Jörg; Reiberger, Thomas; Scharitzer, Martina

Preliminary qualification of a machine learning-based assessment of the tumor immune infiltrate as a predictor of outcome in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab

初步验证基于机器学习的肿瘤免疫浸润评估方法作为阿特珠单抗联合贝伐珠单抗治疗肝细胞癌患者预后预测指标的有效性

Scheiner, Bernhard; Lombardi, Pasquale; D'Alessio, Antonio; Kim, Gwangil; Tafavvoghi, Masoud; Petrenko, Oleksandr; Goldin, Robert D; Fulgenzi, Claudia A M; Torkpour, Aria; Balcar, Lorenz; Mauri, Francesco A; Pomej, Katharina; Himmelsbach, Vera; Barsch, Maryam; Celsa, Ciro; Cabibbo, Giuseppe; Cheon, Jaekyung; Krall, Anja; Hucke, Florian; Di Tommaso, Luca; Bernasconi, Monica; Rimassa, Lorenza; Samson, Adel; Stefanini, Bernardo; Mozayani, Behrang; Trauner, Michael; Lackner, Carolin; Stauber, Rudolf; Vasuri, Francesco; Piscaglia, Fabio; Bengsch, Bertram; Finkelmeier, Fabian; Peck-Radosavljevic, Markus; Rasmussen Busund, Lill-Tove; Marafioti, Teresa; Rahbari, Mohammad; Heikenwalder, Mathias; Pinter, Matthias; Chon, Hong Jae; Rakaee, Mehrdad; Pinato, David J

Second-line treatment patterns and outcomes in advanced HCC after progression on atezolizumab/bevacizumab

阿特珠单抗/贝伐珠单抗治疗进展后晚期肝细胞癌的二线治疗模式和结果

Wu, Meng; Fulgenzi, Claudia A M; D'Alessio, Antonio; Cortellini, Alessio; Celsa, Ciro; Manfredi, Giulia F; Stefanini, Bernardo; Wu, Y Linda; Huang, Yi-Hsiang; Saeed, Anwaar; Pirozzi, Angelo; Pressiani, Tiziana; Rimassa, Lorenza; Schoenlein, Martin; Schulze, Kornelius; von Felden, Johann; Mohamed, Yehia; Kaseb, Ahmed O; Vogel, Arndt; Roehlen, Natascha; Silletta, Marianna; Nishida, Naoshi; Kudo, Masatoshi; Vivaldi, Caterina; Balcar, Lorenz; Scheiner, Bernhard; Pinter, Matthias; Singal, Amit G; Glover, Joshua; Ulahannan, Susanna; Foerster, Fredrich; Weinmann, Arndt; Galle, Peter R; Parikh, Neehar D; Hsu, Wei-Fan; Parisi, Alessandro; Chon, Hong Jae; Pinato, David J; Ang, Celina

Efficacy of atezolizumab plus bevacizumab for unresectable HCC: Systematic review and meta-analysis of real-world evidence

阿特珠单抗联合贝伐珠单抗治疗不可切除肝细胞癌的疗效:真实世界证据的系统评价和荟萃分析

Manfredi, Giulia Francesca; Fulgenzi, Claudia Angela Maria; Celsa, Ciro; Stefanini, Bernardo; D'Alessio, Antonio; Pinter, Matthias; Scheiner, Bernhard; Awosika, Nichola; Brunetti, Leonardo; Lombardi, Pasquale; Latchford, Charles; Lee, Pei-Chang; Huang, Yi-Hsiang; Lin, Chun-Yen; Dalbeni, Andrea; Vogel, Arndt; Galle, Peter R; Kudo, Masatoshi; Rimassa, Lorenza; Chon, Hong Jae; Cabibbo, Giuseppe; Piscaglia, Fabio; Cammà, Calogero; Pillai, Anjana; Pirisi, Mario; Singal, Amit G; Pinato, David J

Lenvatinib vs. sorafenib as second-line treatment post atezolizumab plus bevacizumab for hepatocellular carcinoma: The LEVIATHAN study

乐伐替尼与索拉非尼作为阿特珠单抗联合贝伐珠单抗治疗后肝细胞癌二线治疗的疗效比较:LEVIATHAN 研究

Lombardi, Pasquale; Kim, Jung Sun; Manfredi, Giulia F; Celsa, Ciro; Fulgenzi, Claudia A M; D'Alessio, Antonio; Stefanini, Bernardo; Doshi, Niraj C; Warmington, Emily; Marron, Thomas U; Pinter, Matthias; Scheiner, Bernhard; Kang, Beodeul; Lim, Ho Yeong; Hsu, Wei-Fan; Wietharn, Brooke; Silletta, Marianna; Parisi, Alessandro; Lin, Chun-Yen; Dalbeni, Andrea; Masi, Gianluca; Schönlein, Martin; von Felden, Johann; Piscaglia, Fabio; Galle, Peter R; Kudo, Masatoshi; Pressiani, Tiziana; Rimassa, Lorenza; Pirisi, Mario; Cabibbo, Giuseppe; Chon, Hong Jae; Pinato, David J

Early mortality in atezolizumab/bevacizumab for HCC is associated with impaired liver function and alterations of systemic immunity

阿特珠单抗/贝伐珠单抗治疗肝细胞癌的早期死亡与肝功能受损和全身免疫改变有关。

Piseddu, Ignazio; Jochheim, Leonie S; Boettcher, Katrin; Scheiner, Bernhard; Sinner, Friedrich; Gairing, Simon Johannes; Thaler, Matthias; Enssle, Stefan; Karin, Monika; Zarka, Valentina; Philipp, Alexander; Thalmeier, Andreas; Gaertig, Jan; Balcar, Lorenz; Schütte, Julia Martina; Schneider, Julia S; Ondrejkova, Katarina; Rau, Monika; Weich, Alexander; Anz, David; Berger, Karin; Schulz, Christian; Lange, Christian M; Öcal, Osman; Alunni-Fabbroni, Marianna; Ricke, Jens; Ehmer, Ursula; Venerito, Marino; Foerster, Friedrich; Pinter, Matthias; Geier, Andreas; Mayerle, Julia; De Toni, Enrico N; Reiter, Florian P; Ben Khaled, Najib